A Study on cervicitis with unani formulation

A Single blind placebo controlled trail on warm e unq ur rehem (cervicitis) with aspaghol (pantago ovata) - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/02/081469

Enrollment

Registered

2025-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri Health Condition 2: N72- Inflammatory disease of cervix uteri

Interventions

Control Intervention1: Suboos e Aspaghol Luab e Aspaghol: Suboos e aspaghol orally 5grams twice daily for 10 days Luab e aspaghol as humool (vaginal pessary) daily for 10 days

Eligibility

Inclusion criteria

Inclusion criteria: Married women with sign&symptoms of cervicitis

Exclusion criteria

Exclusion criteria: Pregnancy Positive results in pap smear Fibroid Prolapse Endometriosis

Design outcomes

Primary

Measure	Time frame
Relief of symptomsTimepoint: 12 weeks	—

Secondary

Measure	Time frame
relief of symptomsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr A Suhasini

govt. nizamia tibbi college

drasuhasini12@gmail.com9949586899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026